Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.
Horn P, Norlin J, Almholt K, Viuff BM, Galsgaard ED, Hald A, Zosel F, Demuth H, Poulsen S, Norby PL, Rasch MG, Vyberg M, Fleckner J, Werge MP, Gluud LL, Rink MR, Shepherd E, Northall E, Lalor PF, Weston CJ, Fog-Tonnesen M, Newsome PN.
Horn P, et al. Among authors: weston cj.
Elife. 2024 Oct 3;13:RP95185. doi: 10.7554/eLife.95185.
Elife. 2024.
PMID: 39361025
Free PMC article.